It took more then 3 years and many heated conversations, but it now appears that Management is headed in the right direction.
No more "BOASTS FROM DAVIS WITHOUT RESULTS" we now have a concentration on the one commercial product to have substantial revenue now Mugard. I do believe that we will see increased sales each quarter, and ACCP will become cash flow positive with real earnings.
As for COBALAMIN and PROLINDAC I am not sure that they even work, and even if they would work after many attempts to solve their problems we are looking at results that are not near term.
Mugard is successful; will carry the day, first in the United States, which should make ACCP a $6.00 stock in 2012, and then the rest of the World which should move ACCP to $15 in 2013.
ACCP is a very good speculation in this market and once people realize that they will be cash flow positive, that will remove the many doubts that exist for this tiny biotech.
For those with positions I reccomend holding until the Sept CC, those wanting to start a position remember this trades very thin and you just can not get a lot of shares without moving the stock price, best to put in orders and hope you get a seller in this market
I hate you Robert, almost as much as that skiidady. I'll never forgive you for posting on my COIN message board while I was trying to run a scam with all my ID's. Now I'll one star you until the end of time. It's sad what my life has been reduced to......